DeepMed Research

ABBVIE

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 2013-01-01

Employees: -

Market Cap: $346B

Website: http://www.abbvie.com

Clinical Trials

A Study to Evaluate Chronic Hepatitis C Infection in Adult Transplant Recipients

Phase 2

Completed

Conditions: Chronic Hepatitis C Infection

Interventions: Drug: ombitasvir/paritaprevir/ritonavir and dasabuvir
Drug: ombitasvir/paritaprevir/ritonavir
Drug: ribavirin

First Posted Date: 2013-02-04

Last Posted Date: 2017-11-07

Lead Sponsor: AbbVie

Target Recruit Count: 129

Registration Number: NCT01782495

Rheumatoid Arthritis Patients on Adalimumab to Evaluate Its Effect on Synovitis Using Ultrasonography in an Egyptian Population

Terminated

Conditions: Rheumatoid Arthritis

First Posted Date: 2013-02-04

Last Posted Date: 2015-07-30

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 16

Registration Number: NCT01782469

A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

Phase 2

Completed

Conditions: Acute Kidney Injury

Interventions: Drug: ABT-719
Drug: Placebo

First Posted Date: 2013-01-28

Last Posted Date: 2021-07-07

Lead Sponsor: AbbVie

Target Recruit Count: 240

Registration Number: NCT01777165

Locations: 🇺🇸
Site Reference ID/Investigator# 87720, Gainesville, Florida, United States
🇺🇸
Site Reference ID/Investigator# 83746, Jacksonville, Florida, United States
🇺🇸
Site Reference ID/Investigator# 83733, Jacksonville, Florida, United States

and more 38 locations

A Follow up Study Designed to Obtain Long Term Data on Participants Who Either Achieved a Sustained Virologic Response or Did Not Achieve a Sustained Virologic Response in an AbbVie Sponsored Hepatitis C Study

Phase 3

Completed

Conditions: Hepatitis C

Interventions: Drug: ABT-450/ritonavir
Drug: ABT-333
Drug: ABT-267

First Posted Date: 2013-01-23

Last Posted Date: 2017-12-06

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 478

Registration Number: NCT01773070

Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn's Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice

Completed

Conditions: Plaque Psoriasis
Ankylosing Spondylitis
Crohn´s Disease
Psoriatic Arthritis
Ulcerative Colitis
Rheumatoid Arthritis

Interventions: Drug: Adalimumab

First Posted Date: 2013-01-16

Last Posted Date: 2019-01-28

Lead Sponsor: AbbVie

Target Recruit Count: 96

Registration Number: NCT01768858

A Study to Evaluate Chronic Hepatitis C Infection in Adults With Genotype 1b Infection

Phase 3

Completed

Conditions: Chronic Hepatitis C Infection

Interventions: Drug: ABT-450/r/ABT-267, ABT-333
Drug: Placebo for ribavirin
Drug: Ribavirin

First Posted Date: 2013-01-14

Last Posted Date: 2021-07-12

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 419

Registration Number: NCT01767116

Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Adults With Moderate to Severe Endometriosis-Associated Pain

Phase 3

Completed

Conditions: Endometriosis

Interventions: Drug: Elagolix

First Posted Date: 2013-01-04

Last Posted Date: 2021-07-13

Lead Sponsor: AbbVie

Target Recruit Count: 506

Registration Number: NCT01760954

An Observational Study of Fecal Calprotectin as Clinical Tool in Monitoring Moderate-to-severe Crohn's Disease on Adalimumab Induction Therapy: a KoRean Experience (FAIR)

Completed

Conditions: Crohn's Disease

First Posted Date: 2013-01-03

Last Posted Date: 2015-07-08

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 101

Registration Number: NCT01759264

Post Marketing Observational Study on Paricalcitol IV Administered to Venezuelan Patients

Terminated

Conditions: Hemodialysis
Chronic Kidney Disease Stage V

First Posted Date: 2013-01-01

Last Posted Date: 2014-11-17

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Target Recruit Count: 105

Registration Number: NCT01758289

Locations: 🇻🇪
Site Reference ID/Investigator# 96763, Monagas, Venezuela
🇻🇪
Site Reference ID/Investigator# 96757, Acarigua, Venezuela
🇻🇪
Site Reference ID/Investigator# 96766, Barquisimeto, Venezuela

and more 5 locations

Post Marketing Observational Study on Venezuelan Patients With Psoriasis

Withdrawn

Conditions: Moderate to Severe Chronic Plaque Psoriasis

First Posted Date: 2013-01-01

Last Posted Date: 2016-11-29

Lead Sponsor: AbbVie (prior sponsor, Abbott)

Registration Number: NCT01758705

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy